These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2706526)

  • 21. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.
    Ladner CJ; Lee JM
    Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of muscarinic receptor concentration and subtypes following lesion of rat substantia innominata.
    de Belleroche J; Gardiner IM; Hamilton MH; Birdsall NJ
    Brain Res; 1985 Aug; 340(2):201-9. PubMed ID: 4027649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of vagal autotransplantation and bifemelane hydrochloride on cholinergic markers and event-related potentials in rats with lesions of the nucleus basalis magnocellularis.
    Ikeda K; Egashira T; Yamashita J; Okoyama S
    Brain Res; 1995 Aug; 688(1-2):171-83. PubMed ID: 8542304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease.
    Lange KW; Wells FR; Jenner P; Marsden CD
    J Neurochem; 1993 Jan; 60(1):197-203. PubMed ID: 8417140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.
    Forray C; el-Fakahany EE
    Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increases in muscarinic stimulated hydrolysis of inositol phospholipids in rat hippocampus following cholinergic deafferentation are not parallelled by alterations in cholinergic receptor density.
    Smith CJ; Court JA; Keith AB; Perry EK
    Brain Res; 1989 Apr; 485(2):317-24. PubMed ID: 2720416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
    Baker SP; Posner P
    Mol Pharmacol; 1986 Nov; 30(5):411-8. PubMed ID: 3773882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sialic acid residues as catalysts for M2-muscarinic agonist-receptor interactions.
    Haddad EB; Landry Y; Gies JP
    Mol Pharmacol; 1990 May; 37(5):682-8. PubMed ID: 1692606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ; Tran LP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presynaptic muscarinic receptors on dopaminergic terminals in the nucleus accumbens.
    De Belleroche J; Kilpatrick IC; Birdsall NJ; Hulme EC
    Brain Res; 1982 Feb; 234(2):327-37. PubMed ID: 7059834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-affinity agonist binding to rat brainstem muscarinic receptors is eliminated by low pH.
    Anthony BL; Aronstam RS
    Neurosci Lett; 1986 Aug; 69(1):84-8. PubMed ID: 3748469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solubilization and characterization of high and low affinity pirenzepine binding sites from rat cerebral cortex.
    Berrie CP; Birdsall NJ; Hulme EC; Keen M; Stockton JM
    Br J Pharmacol; 1985 Jul; 85(3):697-703. PubMed ID: 4027484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoradiographic localization of M1 and M2 muscarine receptors in the rat brain.
    Mash DC; Potter LT
    Neuroscience; 1986 Oct; 19(2):551-64. PubMed ID: 3774154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats.
    Araki T; Tanji H; Fujihara K; Kato H; Imai Y; Mizugaki M; Itoyama Y
    J Neural Transm (Vienna); 2000; 107(8-9):873-84. PubMed ID: 11041269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
    Flynn DD; Mash DC
    J Pharmacol Exp Ther; 1989 Aug; 250(2):573-81. PubMed ID: 2760841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscarinic cholinergic receptor subtype on frog esophageal peptic cells: binding and secretion studies.
    Dickinson KE; Matsumoto H; Anderson W; Pruitt RE; Uemura N; Hirschowitz BI
    J Pharmacol Exp Ther; 1988 Sep; 246(3):879-86. PubMed ID: 2901489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional decreases of cortical choline acetyltransferase after lesions of the septal area and in the area of nucleus basalis magnocellularis.
    Hartgraves SL; Mensah PL; Kelly PH
    Neuroscience; 1982 Oct; 7(10):2369-76. PubMed ID: 7177378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple cholinergic markers are unexpectedly not altered in the rat dentate gyrus following entorhinal cortex lesions.
    Aubert I; Poirier J; Gauthier S; Quirion R
    J Neurosci; 1994 May; 14(5 Pt 1):2476-84. PubMed ID: 8182423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nucleus basalis magnocellularis: optimal coordinates for selective reduction of choline acetyltransferase in frontal neocortex by ibotenic acid injections.
    Wenk GL; Cribbs B; McCall L
    Exp Brain Res; 1984; 56(2):335-40. PubMed ID: 6479267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple heteroreceptors on limbic thalamic axons: M2 acetylcholine, serotonin1B, beta 2-adrenoceptors, mu-opioid, and neurotensin.
    Vogt BA; Crino PB; Jensen EL
    Synapse; 1992 Jan; 10(1):44-53. PubMed ID: 1311129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.